CMCAX
Price
$67.36
Change
+$0.82 (+1.23%)
Updated
May 13 closing price
Net Assets
555.02M
PCLPX
Price
$6.42
Change
+$0.09 (+1.42%)
Updated
May 13 closing price
Net Assets
4.17B
Ad is loading...

CMCAX vs PCLPX

Header iconCMCAX vs PCLPX Comparison
Open Charts CMCAX vs PCLPXBanner chart's image
VanEck CM Commodity Index A
Price$67.36
Change+$0.82 (+1.23%)
VolumeN/A
Net Assets555.02M
PIMCO CommoditiesPLUS® Strategy I2
Price$6.42
Change+$0.09 (+1.42%)
VolumeN/A
Net Assets4.17B
CMCAX vs PCLPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMCAX vs. PCLPX commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMCAX is a Hold and PCLPX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PCLPX has more cash in the bank: 4.17B vs. CMCAX (555M). PCLPX pays higher dividends than CMCAX: PCLPX (8.94) vs CMCAX (3.32). CMCAX was incepted earlier than PCLPX: CMCAX (14 years) vs PCLPX (15 years). CMCAX (1.31) is less costly to investors than PCLPX (1.10). CMCAX has a lower initial minimum investment than PCLPX: CMCAX (1000) vs PCLPX (1000000). CMCAX annual gain was more profitable for investors over the last year : -2.15 vs. PCLPX (-3.15). PCLPX return over 5 years is better than : 183.58 vs. CMCAX (116.19).
CMCAXPCLPXCMCAX / PCLPX
Total Expense Ratio0.950.93102%
Annual Report Gross Expense Ratio1.311.10119%
Fund Existence14 years15 years-
Gain YTD0.808-2.259-36%
Front Load6%N/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets555M4.17B13%
Annual Yield % from dividends3.328.9437%
Returns for 1 year-2.15-3.1568%
Returns for 3 years-3.19-3.20100%
Returns for 5 years116.19183.5863%
Returns for 10 years40.4160.8666%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCRB7.880.83
+11.69%
Seres Therapeutics Inc
CRMT52.893.60
+7.30%
America's Car-Mart
ARQT14.390.86
+6.36%
Arcutis Biotherapeutics
C74.913.46
+4.84%
Citigroup
RHP101.304.19
+4.31%
Ryman Hospitality Properties